Susquehanna International Group’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-9,350
| Closed | -$46.8K | – | 13639 |
|
|
2024
Q3 | $46.8K | Sell |
9,350
-1,420
| -13% | -$9.22K | ﹤0.01% | 11407 |
|
|
2024
Q2 | $71.1K | Buy |
10,770
+7,410
| +221% | +$50.4K | ﹤0.01% | 11238 |
|
|
2024
Q1 | $37K | Sell |
3,360
-38,130
| -92% | -$413K | ﹤0.01% | 11651 |
|
|
2023
Q4 | $560K | Buy |
41,490
+4,260
| +11% | +$69.1K | ﹤0.01% | 8376 |
|
|
2023
Q3 | $808K | Sell |
37,230
-1,170
| -3% | -$37.5K | ﹤0.01% | 7127 |
|
|
2023
Q2 | $1.48M | Buy |
38,400
+1,280
| +3% | +$45.1K | ﹤0.01% | 5798 |
|
|
2023
Q1 | $1.03M | Buy |
37,120
+35,523
| +2,224% | +$1.2M | ﹤0.01% | 6739 |
|
|
2022
Q4 | $51.9K | Sell |
1,597
-856
| -35% | -$62.4K | ﹤0.01% | 11374 |
|
|
2022
Q3 | $294K | Sell |
2,453
-623
| -20% | -$112K | ﹤0.01% | 9848 |
|
|
2022
Q2 | $538K | Sell |
3,076
-520
| -14% | -$110K | ﹤0.01% | 8085 |
|
|
2022
Q1 | $1.04M | Sell |
3,596
-3,789
| -51% | -$1.44M | ﹤0.01% | 7003 |
|
|
2021
Q4 | $3.86M | Buy |
7,385
+4,359
| +144% | +$3.13M | ﹤0.01% | 4192 |
|
|
2021
Q3 | $1.15M | Buy |
3,026
+2,938
| +3,339% | +$1.26M | ﹤0.01% | 7208 |
|
|
2021
Q2 | $79K | Buy |
88
+30
| +52% | +$22.9K | ﹤0.01% | 12182 |
|
|
2021
Q1 | $69K | Buy |
+58
| New | +$80K | ﹤0.01% | 11973 |
|
Susquehanna International Group's BIOR Position: Q1 2024 in Review
Susquehanna International Group sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2024, closing a stake of 5,085 shares — an estimated $55K sold.
Susquehanna International Group first reported a position in BIOR in Q1 2021 and held it in 11 quarters. The position peaked at $3.23M in Q4 2021. 27 funds tracked by Wall St. Rank hold BIOR as of Q1 2024.
- Susquehanna International Group reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Susquehanna International Group sold 5,085 Biora Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $55K.
- Susquehanna International Group first reported a position in Biora Therapeutics, Inc. Common Stock in Q1 2021 and held it in 11 quarters.
- Susquehanna International Group's Biora Therapeutics, Inc. Common Stock position peaked at $3.23M in Q4 2021.
- 27 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2024.
Based on Susquehanna International Group's 13F filing for Q1 2024, filed 7 May 2024.